Client: Peter McCallum Cancer Centre | Trans Tasman Radiation Oncology Group (TROG)
Context: This trial is trying to understand if Stereotactic radiotherapy could work as an effective treatment for patients with Oligoprogressive ER-positive Breast Cancer (ER-positive, HER2-negative advanced breast cancer) that have had partial response to prior treatment.
For more information, see: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12620001212943
